Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (2): 249-254. doi: 10.19723/j.issn.1671-167X.2022.02.008

Previous Articles     Next Articles

Incidence and risk factors of ischemic stroke in patients with type 2 diabetes among urban workers in Beijing, China

WU Jun-hui,WU Yi-qun,WU Yao,WANG Zi-jing,WU Tao,QIN Xue-ying,WANG Meng-ying,WANG Xiao-wen,WANG Jia-ting,HU Yong-hua()   

  1. Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China
  • Received:2020-04-27 Online:2022-04-18 Published:2022-04-13
  • Contact: Yong-hua HU E-mail:yhhu@bjmu.edu.cn
  • Supported by:
    National Natural Science Foundation of China(81230066);National Natural Science Foundation of China(81473043);National Natural Science Foundation of China(81703291);National Natural Science Foundation of China(81872695)

RICH HTML

   

PDF (PC)

Abstract:

Objective: To explore the incidence of ischemic stroke after the onset of type 2 diabetes, and further analyze the risk factors, so as to provide a basis for further research. Methods: The data were obtained from the database of the Beijing Urban Employee Basic Medical Insurance Database. The study used a prospective design to describe the incidence of ischemic stroke in patients with type 2 diabetes. In our study, these patients were followed up for seven years. Multivariate Logistic regression models were used to analyze the risk factors of ischemic stroke in patients with type 2 diabetes. Results: A total of 185 813 newly diagnosed type 2 diabetes patients were enrolled, with an average age of (58.5±13.2) years, and 49.0% of them were males. A total of 10 393 patients with newly diagnosed ischemic stroke occurred in 7 years, with a cumulative incidence of 5.6% and an incidence density of 8.1/1 000 person-years. Ischemic stroke occurred in all age groups in patients with type 2 diabetes. The cumulative incidence was 1.5% (95%CI: 1.3%-1.6%) in group ≤44 years old, 3.6% (95%CI: 3.4%-3.7%) in group 45-54 years old, 5.4% (95%CI: 5.2%-5.5%) in group 55-64 years old, and 9.2% (95%CI: 9.0%-9.4%) in group ≥65 years old, and the cumulative incidence increased with age (P<0.05). Cumulative incidence rate of the males (6.8%, 95%CI: 6.7%-7.0%) was higher than the females (4.4%, 95%CI: 4.3%-4.6%). Among the patients <80 years old, the cumulative incidence rate of the males was higher than that of the females in all the age groups. In the patients ≥80 years of age, the cumulative incidence was higher in the females (9.2%) than in the males (7.9%). Further analysis revealed that complications, such as coronary heart disease (OR=3.18, 95%CI: 2.72-3.72), heart failure (OR=1.53, 95%CI: 1.32-1.79) and kidney failure (OR=1.45, 95%CI: 1.20-1.75) were associated with ischemic stroke in the patients with type 2 diabetes. Conclusion: The incidence level of ischemic stroke in patients with type 2 diabetes is high. It is necessary to strengthen the management of risk factors in elderly patients, screen the complications of type 2 diabetes as early as possible, and take active preventive and control measures.

Key words: Diabetes mellitus, type 2, Stroke, Diabetes complication, Incidence

CLC Number: 

  • R181.32

Table 1

Characteristics of adult type 2 diabetes patients in Beijing"

Characteristics Male (n=90 948) Female (n=94 865) χ2 P Total (n=185 813)
Age group, n(%) 2 318.82 <0.01
≤44 years 11 572 (12.72) 10 177 (10.73) 21 749 (11.71)
45-54 years 21 208 (23.32) 31 568 (33.28) 52 776 (13.91)
55-64 years 27 241 (29.95) 25 984 (27.39) 53 225 (28.40)
≥65 years 30 927 (34.01) 27 136 (28.60) 58 063 (28.64)
Comorbidity, n(%)
Coronary heart disease 2 710 (2.98) 2 261 (2.38) 63.42 <0.01 4 971 (2.67)
Heart failure 1 103 (1.21) 794 (0.84) 64.89 <0.01 1 897 (1.02)
Kidney failure 917 (1.01) 591 (0.62) 85.62 <0.01 1 508 (0.81)

Table 2

Cumulative incidence of ischemic stroke in adult type 2 diabetes patients in Beijing"

Follow-up Male Female Total
n Cumulative
incidence/%		 95%CI n Cumulative
incidence/%		 95%CI n Cumulative
incidence/%		 95%CI
1 year 1 069 1.18 1.11-1.25 637 0.67 0.62-0.72 1 706 0.92 0.87-0.96
2 years 1 809 1.99 1.90-2.08 1 092 1.15 1.08-1.22 2 901 1.56 1.50-1.62
3 years 2 672 2.94 2.83-3.05 1 668 1.76 1.67-1.84 4 340 2.34 2.27-2.40
4 years 3 565 3.92 3.79-4.05 2 222 2.34 2.25-2.44 5 787 3.11 3.04-3.19
5 years 4 472 4.92 4.78-5.06 2 888 3.04 2.93-3.15 7 360 3.96 3.87-4.05
6 years 5 337 5.87 5.72-6.02 3 563 3.73 3.63-3.88 8 900 4.79 4.69-4.89
7 years 6 201 6.82 6.65-6.98 4 195 4.42 4.29-4.55 10 396 5.59 5.49-5.70

Table 3

Cumulative incidence of ischemic stroke in adult type 2 diabetes patients in Beijing (stratified by age)"

Follow-up ≤44 years 45-54 years
n Cumulative incidence(95%CI) n Cumulative incidence(95%CI)
1 year 34 0.16 (0.10-0.21) 279 0.53 (0.47-0.59)
2 years 65 0.30 (0.23-0.37) 469 0.89 (0.81-0.97)
3 years 109 0.50 (0.41-0.60) 716 1.36 (1.26-1.46)
4 years 152 0.70 (0.59-0.81) 958 1.82 (1.70-1.93)
5 years 213 0.98 (0.85-1.11) 1 282 2.43 (2.30-2.56)
6 years 263 1.21 (1.06-1.35) 1 575 2.98 (2.84-3.13)
7 years 319 1.48 (1.31-1.63) 1 880 3.56 (3.40-3.72)
Follow-up 55-64 years ≥65 years
n Cumulative incidence(95%CI) n Cumulative incidence(95%CI)
1 year 425 0.80 (0.72-0.87) 968 1.67 (1.56-1.77)
2 years 737 1.38 (1.29-1.48) 1 630 2.81 (2.67-2.94)
3 years 1 092 2.05 (1.93-2.17) 2 423 4.17 (4.01-4.34)
4 years 1 517 2.85 (2.71-2.99) 3 160 5.54 (5.26-5.63)
5 years 1 955 3.67 (3.51-3.83) 3 910 6.73 (6.53-6.94)
6 years 2 394 4.50 (4.32-4.67) 4 668 8.04 (7.82-8.26)
7 years 2 847 5.35 (5.16-5.54) 5 347 9.21 (8.97-9.44)

Figure 1

Cumulative incidence of ischemic stroke in adult type 2 diabetes patients in Beijing (stratified by gender and age)"

Table 4

Incidence density of ischemic stroke in adult type 2 diabetes patients in Beijing"

Items Male patients with ischemic stroke Female patients with ischemic stroke Total
n Incidence
densitya		 95%CI n Incidence
densitya		 95%CI n Incidence
densitya		 95%CI
Total 6 021 9.94 9.69-10.19 4 195 6.39 6.20-6.59 10 393 8.12 7.97-8.28
Age group
≤44 years 238 2.94 2.57-3.31 81 1.14 0.89-1.38 319 2.10 1.87-2.33
45-54 years 1 113 7.50 7.06-7.94 767 3.47 3.23-3.72 1 880 5.09 4.86-5.32
55-64 years 1 882 9.87 9.43-10.31 965 5.31 4.97-5.64 2 847 7.64 7.36-7.92
≥65 years 2 962 13.68 13.19-14.17 2 385 12.56 12.06-13.06 5 347 12.97 12.50-13.43

Table 5

Multivariate Logistic regression analysis of the risk factors of ischemic stroke in type 2 diabetes mellitus patients"

Variable Model 1 Model 2 Model 3
OR 95%CI P OR 95%CI P OR 95%CI P
Male 1.48 1.42-1.54 <0.01 1.40 1.34-1.46 <0.01 1.39 1.33-1.45 <0.01
Age 1.04 1.04-1.04 <0.01 1.04 1.04-1.04 <0.01 1.04 1.04-1.04 <0.01
Use of insulin 0.50 0.48-0.53 <0.01 0.51 0.49-0.54 <0.01
Use of metformin 0.56 0.54-0.59 <0.01 0.57 0.54-0.59 <0.01
Coronary heart disease 3.18 2.72-3.72 <0.01
Heart failure 1.53 1.32-1.79 <0.01
Kidney failure 1.45 1.20-1.75 <0.01
[1] Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: Glo-bal estimates of diabetes prevalence for 2017 and projections for 2045[J]. Diabetes Res Clin Pract, 2018, 138:271-281.
doi: 10.1016/j.diabres.2018.02.023
[2] Feigin VL, Roth GA, Naghavi M, et al. Global burden of stroke and risk factors in 188 countries, during 1990-2013: A systema-tic analysis for the global burden of disease study 2013[J]. Lancet Neurol, 2016, 15(9):913-924.
doi: 10.1016/S1474-4422(16)30073-4
[3] Yang R, Pedersen NL, Bao C, et al. Type 2 diabetes in midlife and risk of cerebrovascular disease in late life: A prospective nested case-control study in a nationwide Swedish twin cohort[J]. Diabetologia, 2019, 62(8):1403-1411.
doi: 10.1007/s00125-019-4892-3
[4] Kissela BM, Khoury J, Kleindorfer D, et al. Epidemiology of ischemic stroke in patients with diabetes: The greater Cincinnati/Northern Kentucky stroke study[J]. Diabetes Care, 2005, 28(2):355-359.
doi: 10.2337/diacare.28.2.355 pmid: 15677792
[5] Huang ES, Laiteerapong N, Liu JY, et al. Rates of complications and mortality in older patients with diabetes mellitus: The diabetes and aging study[J]. JAMA Intern Med, 2014, 174(2):251-258.
doi: 10.1001/jamainternmed.2013.12956
[6] Staszewsky L, Cortesi L, Baviera M, et al. Diabetes mellitus as risk factor for atrial fibrillation hospitalization: Incidence and outcomes over nine years in a region of Northern Italy[J]. Diabetes Res Clin Pract, 2015, 109(3):476-484.
doi: 10.1016/j.diabres.2015.06.006
[7] Li J, Dong Y, Wu T, et al. Differences between Western and Asian type 2 diabetes patients in the incidence of vascular complications and mortality: A systematic review of randomized controlled trials on lowering blood glucose[J]. J Diabetes, 2016, 8(6):824-833.
doi: 10.1111/1753-0407.12361
[8] Mulnier HE, Seaman HE, Raleigh VS, et al. Risk of stroke in people with type 2 diabetes in the UK: A study using the general practice research database[J]. Diabetologia, 2006, 49(12):2859-2865.
pmid: 17072582
[9] Giorda CB, Avogaro A, Maggini M, et al. Incidence and risk factors for stroke in type 2 diabetic patients: The DAI study[J]. Stroke, 2007, 38(4):1154-1160.
pmid: 17332448
[10] Gong Q, Zhang P, Wang J, et al. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing diabetes prevention outcome study[J]. Lancet Diabetes Endocrinol, 2019, 7(6):452-461.
doi: 10.1016/S2213-8587(19)30093-2
[11] Banerjee C, Moon YP, Paik MC, et al. Duration of diabetes and risk of ischemic stroke: The Northern Manhattan study[J]. Stroke, 2012, 43(5):1212-1217.
doi: 10.1161/STROKEAHA.111.641381
[12] 任晓宇, 史典, 张德生, 等. 金昌队列人群代谢性疾病与脑卒中发病关系前瞻性研究[J]. 中华流行病学杂志, 2019, 40(5):521-525.
[13] 沈卓之, 丁贤彬, 毛德强, 等. 2015年重庆市常住人口脑卒中发病与死亡情况[J]. 公共卫生与预防医学, 2016, 27(5):48-51.
[14] 韩荣荣, 唐爱奇, 方杭燕, 等. 2型糖尿病患者并发脑卒中的前瞻性研究[J]. 预防医学, 2017, 29(2):139-141.
[15] Luk AOY, Hui EMT, Sin MC, et al. Declining trends of cardiovascular-renal complications and mortality in type 2 diabetes: The Hong Kong diabetes database[J]. Diabetes Care, 2017, 40(7):928-935.
doi: 10.2337/dc16-2354
[16] Shen Y, Shi L, Nauman E, et al. Race and sex differences in rates of diabetic complications[J]. J Diabetes, 2019, 11(6):449-456.
doi: 10.1111/1753-0407.12869 pmid: 30315628
[17] Wang Y, Dai Y, Zheng J, et al. Sex difference in the incidence of stroke and its corresponding influence factors: Results from a follow-up 8.4 years of rural China hypertensive prospective cohort study[J]. Lipids Health Dis, 2019, 18(1):72.
doi: 10.1186/s12944-019-1010-y
[18] Barker-Collo S, Bennett DA, Krishnamurthi RV, et al. Sex diffe-rences in stroke incidence, prevalence, mortality and disability-adjusted life years: Results from the global burden of disease study 2013[J]. Neuroepidemiology, 2015, 45(3):203-214.
doi: 10.1159/000441103 pmid: 26505984
[19] Madsen TE, Khoury JC, Alwell KA, et al. Sex differences in cardiovascular risk profiles of ischemic stroke patients with diabetes in the Greater Cincinnati/Northern Kentucky stroke study[J]. J Diabetes, 2018, 10(6):496-501.
doi: 10.1111/1753-0407.12567 pmid: 28523847
[20] Petrea RE, Beiser AS, Seshadri S, et al. Gender differences in stroke incidence and poststroke disability in the Framingham heart study[J]. Stroke, 2009, 40(4):1032-1037.
doi: 10.1161/STROKEAHA.108.542894
[21] 申宏, 方旭东. 重庆市巴南区居民2012—2015年脑卒中发病情况分析[J]. 检验医学与临床, 2016, 13(23):3398-3399.
[22] 叶虹. 2型糖尿病合并缺血性脑血管病的相关危险因素研究[D]. 广州: 南方医科大学, 2011.
[23] GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990-2016: A systematic analysis for the glo-bal burden of disease study 2016[J]. Lancet Neurol, 2019, 18(5):439-458.
doi: 10.1016/S1474-4422(19)30034-1
[24] Madan S. Changes in diabetes-related complications in the United States[J]. N Engl J Med, 2014, 371(3):285-286.
[25] Bui HDT, Jing X, Lu R, et al. Prevalence of and factors related to microvascular complications in patients with type 2 diabetes mellitus in Tianjin, China: A cross-sectional study[J]. Ann Transl Med, 2019, 7(14):325.
doi: 10.21037/atm
[1] Hewei MIN, Yibo WU, Yuhui SHI, Mingzi LI, Xinying SUN. Analyzing the influential factors of dietary patterns and blood glucose control in type 2 diabetes patients based on the model of health action process approach model [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1145-1152.
[2] Jingyan GU, Xinyi LI, Jinxia ZHAO, Rong MU. Diabetic Charcot neuroarthropathy initially misdiagnosed as rheumatoid arthritis and gout: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1193-1197.
[3] Pei CAO, Qingxian LUAN. Periodontitis and systemic diseases: Thinking and explorations [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 852-858.
[4] Kun WANG, Huairong WANG, Huan YU, Ruotong YANG, Liuyan ZHENG, Jingxian WU, Xueying QIN, Tao WU, Dafang CHEN, Yiqun WU, Yonghua HU. Identifying genetic etiology of ischemic stroke based on pleiotropy of obesity related genes: A sibling study [J]. Journal of Peking University (Health Sciences), 2025, 57(3): 448-455.
[5] Ziyan CHEN, Xiaoyue ZHANG, Yiwu GU, Chun CHANG. Type 2 diabetes patients use E-health to manage disease willingness and influence mechanisms [J]. Journal of Peking University (Health Sciences), 2025, 57(3): 522-528.
[6] Guangxu LIU, Liang ZHANG, Houyu ZHAO, Siwei DENG, Junting YANG, Ning LI, Rui MA, Yan HE, Guozhang XU, Zhike LIU, Siyan ZHAN. Epidemiological characteristics of febrile seizure among children under 6 years old in Ningbo City from 2015 to 2021 [J]. Journal of Peking University (Health Sciences), 2025, 57(3): 584-591.
[7] Guangyan YU, Xin PENG, Min GAO, Peng YE, Na GE, Mengqi JIA, Bingyu LI, Zunan TANG, Leihao HU, Wenbo ZHANG. Research progress in diagnosis and treatment of salivary gland tumors [J]. Journal of Peking University (Health Sciences), 2025, 57(1): 1-6.
[8] Yaqing MAO, Zhen CHEN, Yao YU, Wenbo ZHANG, Yang LIU, Xin PENG. Impact of type 2 diabetes mellitus on the prognosis of patients with oral squamous cell carcinoma [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 1089-1096.
[9] Peiheng ZHANG, Ying GAO, Honghua WU, Jian ZHANG, Junqing ZHANG. Fulminant type 1 diabetes mellitus with acute pancreatitis: A case report and literature review [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 923-927.
[10] Yujia MA,Ranli LU,Zechen ZHOU,Xiaoyi LI,Zeyu YAN,Yiqun WU,Dafang CHEN. Association between insomnia and type 2 diabetes: A two-sample Mendelian rando-mization study [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 174-178.
[11] Lei BAO,Xia-xia CAI,Ming-yuan ZHANG,Lei-lei REN. Effect of vitamin D3 on mild cognitive impairment in type 2 diabetic mice and its possible mechanism [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 587-592.
[12] Xiao-yue ZHANG,Yu-xin LIN,Ying JIANG,Lan-chao ZHANG,Mang-yan DONG,Hai-yi CHI,Hao-yu DONG,Li-jun MA,Zhi-jing LI,Chun CHANG. Mediating effect of self-efficacy on self-management ability and self-management behavior in patients with type 2 diabetes mellitus [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 450-455.
[13] Huan YU,Ruo-tong YANG,Si-yue WANG,Jun-hui WU,Meng-ying WANG,Xue-ying QIN,Tao WU,Da-fang CHEN,Yi-qun WU,Yong-hua HU. Metformin use and risk of ischemic stroke in patients with type 2 diabetes: A cohort study [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 456-464.
[14] Ruo-tong YANG,Meng-ying WANG,Chun-nan LI,Huan YU,Xiao-wen WANG,Jun-hui WU,Si-yue WANG,Jia-ting WANG,Da-fang CHEN,Tao WU,Yong-hua HU. Interaction between ischemic stroke risk loci identified by genome-wide association studies and sleep habits [J]. Journal of Peking University (Health Sciences), 2022, 54(3): 412-420.
[15] Yu-han DENG,Yong JIANG,Zi-yao WANG,Shuang LIU,Yu-xin WANG,Bao-hua LIU. Long short-term memory and Logistic regression for mortality risk prediction of intensive care unit patients with stroke [J]. Journal of Peking University (Health Sciences), 2022, 54(3): 458-467.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd